Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Kurukulasuriya

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Topics in Medicinal Chemistry|March 14, 2007
Aromatic heterocycle-based DPP-IV inhibitors: xanthines and related structural typesBruce G Szczepankiewicz, Ravi Kurukulasuriya
Organic Letters|April 23, 2005
Synthesis of purines and other fused imidazoles from acyclic amidines and guanidinesBruce G Szczepankiewicz, Jeffrey J Rohde, Ravi Kurukulasuriya
Organic Letters|August 25, 2006
A highly efficient synthesis of potent and selective butyrolactam inhibitors of 11beta-HSD1Vince S C Yeh, Ravi Kurukulasuriya, Francis A Kerdesky
Organic Letters|January 5, 2002
2,2,2-trifluoroethyl formate: a versatile and selective reagent for the formylation of alcohols, amines, and N-hydroxylaminesDavid R Hill, Chi-Nung Hsiao, Ravi Kurukulasuriya, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2006
Synthesis and structural activity relationship of 11beta-HSD1 inhibitors with novel adamantane replacementsVince S C Yeh, Ravi Kurukulasuriya, David Madar, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Biaryl amide glucagon receptor antagonistsRavi Kurukulasuriya, Bryan K Sorensen, James T Link, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2006
Synthesis and biological evaluation of heterocycle containing adamantane 11beta-HSD1 inhibitorsVince S C Yeh, Jyoti R Patel, Hong Yong, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Discovery of orally active butyrolactam 11beta-HSD1 inhibitorsVince S C Yeh, Ravi Kurukulasuriya, Steven Fung, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2006
Xanthine mimetics as potent dipeptidyl peptidase IV inhibitorsRavi Kurukulasuriya, Jeffrey J Rohde, Bruce G Szczepankiewicz, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided ApproachJonathan E Wilson, Ravi Kurukulasuriya, Mikhail Reibarkh, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|March 14, 2007
Aromatic heterocycle-based DPP-IV inhibitors: xanthines and related structural typesBruce G Szczepankiewicz, Ravi Kurukulasuriya
Organic Letters|April 23, 2005
Synthesis of purines and other fused imidazoles from acyclic amidines and guanidinesBruce G Szczepankiewicz, Jeffrey J Rohde, Ravi Kurukulasuriya
Organic Letters|August 25, 2006
A highly efficient synthesis of potent and selective butyrolactam inhibitors of 11beta-HSD1Vince S C Yeh, Ravi Kurukulasuriya, Francis A Kerdesky
Organic Letters|January 5, 2002
2,2,2-trifluoroethyl formate: a versatile and selective reagent for the formylation of alcohols, amines, and N-hydroxylaminesDavid R Hill, Chi-Nung Hsiao, Ravi Kurukulasuriya, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2006
Synthesis and structural activity relationship of 11beta-HSD1 inhibitors with novel adamantane replacementsVince S C Yeh, Ravi Kurukulasuriya, David Madar, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Biaryl amide glucagon receptor antagonistsRavi Kurukulasuriya, Bryan K Sorensen, James T Link, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2006
Synthesis and biological evaluation of heterocycle containing adamantane 11beta-HSD1 inhibitorsVince S C Yeh, Jyoti R Patel, Hong Yong, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Discovery of orally active butyrolactam 11beta-HSD1 inhibitorsVince S C Yeh, Ravi Kurukulasuriya, Steven Fung, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2006
Xanthine mimetics as potent dipeptidyl peptidase IV inhibitorsRavi Kurukulasuriya, Jeffrey J Rohde, Bruce G Szczepankiewicz, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided ApproachJonathan E Wilson, Ravi Kurukulasuriya, Mikhail Reibarkh, et al.
Pageof 2